Dencare 2026Q3: Revenue of 464 million yuan, up 20.16% year-on-year; non-recurring net profit attributable to shareholders of the parent company up over 30%

Source: Dengkang Stomatology 2026 Third Quarter Report

Q3 Non-recurring-adjusted Net Profit Attributable to Shareholders of the Parent Company Up 32.54% / Q3 Revenue Up 20.16% / First Three Quarters Net Profit Attributable to Shareholders of the Parent Company Up 18.32%

DentalGoodNews｜On October 22, 2026, Dencare (Chongqing) Oral Care Co., Ltd. (hereinafter referred to as "Dencare") released its unaudited third-quarter 2026 report. The report shows that third-quarter single-quarter operating revenue was 464 million yuan, up 20.16% year on year; net profit attributable to shareholders of the listed company (Net Profit Attributable to Shareholders of the Parent Company) was 59.3952 million yuan, up 17.09% year on year; net profit attributable to shareholders of the parent company after deducting non-recurring gains and losses (non-recurring-adjusted net profit attributable to shareholders of the parent company) was 54.7635 million yuan, up 32.54% year on year.

Cumulative operating revenue for the first three quarters was 1.425 billion yuan, up 16.05% year on year; Net Profit Attributable to Shareholders of the Parent Company was 161 million yuan, up 18.32% year on year; non-recurring-adjusted net profit attributable to shareholders of the parent company was 147 million yuan, up 32.43% year on year. According to previous DGN reports, Dencare's operating revenue in the first half of 2026 increased 14.16% year on year, Net Profit Attributable to Shareholders of the Parent Company increased 19.05% year on year, and non-recurring-adjusted net profit attributable to shareholders of the parent company increased 32.36% year on year.

Source: Dengkang Stomatology 2026 Third Quarter Report

Calculated based on the current-period and prior-period amounts presented in the statements, operating costs for the first three quarters were 676 million yuan, up 11.14% year on year, lower than the revenue growth rate; Gross Margin was 52.59%, compared with 50.50% in the same period last year, an increase of 2.10 percentage points; Operating Profit was 185 million yuan, up 22.66% year on year. Selling expenses were 477 million yuan, up 17.58% year on year, accounting for 33.48% of operating revenue, compared with 33.04% in the same period last year; administrative expenses were 55.9807 million yuan, up 19.42% year on year; R&D expenses were 44.3403 million yuan, up 10.27% year on year.

Source: Dengkang Stomatology 2026 Third Quarter Report

In terms of assets and cash flow, as of September 30, 2026, Accounts Receivable were 49.8083 million yuan, up 76.77% from the end of the previous year. The report stated that this was mainly due to growth in e-commerce B2B sales and fluctuations in settlement timing. Net Cash Flow from Operating Activities for the first three quarters was 140 million yuan, down 20.77% year on year, 0.87 times the Net Profit Attributable to Shareholders of the Parent Company for the same period; other cash paid related to operating activities was 274 million yuan, up 37.58% year on year. The report stated that this was mainly due to increased investment in selling expenses.